|Articles|August 25, 2017
List of New Specialty Drug Indications Highlight SPT Week in Review
Author(s)Specialty Pharmacy Times Staff
Top news of the week from Specialty Pharmacy Times.
Advertisement
5. Chronic Inflammation in Rheumatoid Arthritis Attributed to Hibernating Cells
Hibernating innate lymphoid cells allows inflammation to persist in rheumatoid arthritis.
4. FDA Accepts Supplemental Biologics License Application for Lymphoma Drug
Brentuximab vedotin under evaluation for the treatment of cutaneous T-cell lymphoma.
3. Novel Leukemia Drug Gets FDA Orphan Drug Designation
A first-in-class selective retinoic acid receptor alpha agonist is being tested in phase 2 clinical trials for acute myeloid leukemia and myelodysplastic syndrome.
2. Top 5 Highest Grossing Specialty Drugs of the Year
Drugs that treat autoimmune disorders and hepatitis C virus power specialty drug spending.
1. New Specialty Drug Indications of 2017
Treatments for hepatitis C, hemophilia, and cholesterol among specialty drugs approved for new indications this year.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
5
